bioMérieux Stock Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 8.6B 9.96B 8.08B 7.35B 13.82B 952B 14.05B 94.73B 37.04B 477B 37.4B 36.59B 1,585B | P/E 2026 * |
17.9x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 8.2B 9.49B 7.7B 7B 13.17B 907B 13.39B 90.24B 35.28B 454B 35.63B 34.85B 1,510B | EV / Sales 2026 * |
1.99x | EV / Sales 2027 * | 1.81x |
| Free-Float |
33.22% | Yield 2026 * |
1.43% | Yield 2027 * | 1.58% |
Last Transcript: bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 01/07/2023 |
| Director of Finance/CFO | 50 | 01/03/2018 | |
| Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 15/12/2017 | |
| Director/Board Member | 66 | 01/01/2005 | |
| Director/Board Member | 61 | 30/05/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.25% | - | - | 9.96B | |
| -1.46% | -6.69% | +167.00% | +344.22% | 21.1B | |
| +0.14% | +0.34% | -41.94% | -22.13% | 9.96B | |
| -3.54% | +7.80% | +319.84% | +15.10% | 7.31B | |
| +0.01% | 0.00% | +86.32% | +47.48% | 6.59B | |
| -1.71% | -4.13% | -40.27% | - | 6.16B | |
| +3.22% | +6.11% | -12.93% | -8.19% | 5.97B | |
| +1.19% | +0.81% | +81.12% | +112.57% | 4.55B | |
| -0.64% | -1.30% | -11.45% | -18.47% | 4.27B | |
| +3.92% | +3.82% | -19.12% | -32.51% | 2.85B | |
| Average | +0.09% | +2.88% | +58.73% | +54.76% | 7.64B | |
| Weighted average by Cap. | -0.45% | +1.17% | +86.57% | +123.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.12B 4.78B 3.88B 3.52B 6.63B 457B 6.74B 45.41B 17.76B 229B 17.93B 17.54B 760B | 4.34B 5.02B 4.08B 3.71B 6.97B 480B 7.08B 47.76B 18.67B 240B 18.86B 18.45B 799B |
| Net income | 482M 559M 453M 412M 775M 53.41B 788M 5.31B 2.08B 26.74B 2.1B 2.05B 88.88B | 525M 608M 494M 449M 844M 58.16B 858M 5.78B 2.26B 29.12B 2.28B 2.23B 96.78B |
| Net Debt | -408M -472M -383M -348M -655M -45.13B -666M -4.49B -1.76B -22.6B -1.77B -1.73B -75.11B | -731M -847M -687M -625M -1.17B -80.96B -1.19B -8.05B -3.15B -40.54B -3.18B -3.11B -135B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
